A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Conclusions
There was a trend towards a decline in ABPA exacerbations at 1 year with the prednisolone–itraconazole combination versus prednisolone monotherapy. A three-arm trial comparing itraconazole and prednisolone monotherapies with their combination, preferably in a multicentric design, is required to define the best treatment strategy for acute-stage ABPA.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Agarwal, R., Muthu, V., Sehgal, I. S., Dhooria, S., Prasad, K. T., Garg, M., Aggarwal, A. N., Chakrabarti, A. Tags: Asthma and allergy Original Articles: Asthma Source Type: research
More News: Allergy | Allergy & Immunology | Aspergillosis | Asthma | Prednisolone | Respiratory Medicine